The PD-1/PD-L1 inhibitory pathway is altered in pre-eclampsia and regulates T cell responses in pre-eclamptic rats

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Tian, Mei ^a   Zhang, Yonghong ^a   Liu, Zhaozhao ^a   Sun, Guoqiang ^b   Mor, Gil ^c   Liao, Aihua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Maternal and Child Health Hospital of Hubei Province   (China)

^c YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN KINASE B; TARGET OF RAPAMYCIN KINASE;

ADULT; ANIMAL; BLOOD; CYTOLOGY; FEMALE; GENETICS; HUMAN; METABOLISM; PLACENTA; PREECLAMPSIA; PREGNANCY; RAT; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TH17 CELL;

ADULT; ANIMALS; B7-H1 ANTIGEN; FEMALE; HUMANS; PHOSPHATIDYLINOSITOL 3-KINASES; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PROGRAMMED CELL DEATH 1 RECEPTOR; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TOR SERINE-THREONINE KINASES;

EID: 84974575220     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep27683     Document Type: Article

References (60)

1. Khan, K. S., Wojdyla, D., Say, L., Gulmezoglu, A. M., Van Look, P. F. WHO analysis of causes of maternal death: a systematic review. Lancet 367, 1066-1074 (2006).
2. Sibai, B., Dekker, G., Kupferminc, M. Pre-eclampsia. Lancet 365, 785-799 (2005).
3. Mor, G., Cardenas, I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol 63, 425-433(2010).
4. Yeh, C. C., Chao, K. C., Huang, S. J. Innate immunity, decidual cells, and preeclampsia. Reprod Sci 20, 339-353 (2013).
5. Saito, S. et al. Increased T-helper-1-type immunity and decreased T-helper-2-type immunity in patients with preeclampsia. Am J Reprod Immunol 41, 297-306 (1999).
6. Saito, S. et al. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol 117, 550-555 (1999).
7. Germain, S. J., Sacks, G. P., Sooranna, S. R., Sargent, I. L., Redman, C. W. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 178, 5949-5956 (2007).
8. Santner-Nanan, B. et al. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J Immunol 183, 7023-7030 (2009).
9. Aluvihare, V. R., Kallikourdis, M., Betz, A. G. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 5, 266-271 (2004).
10. Sasaki, Y. et al. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 10, 347-353 (2004).
11. Saito, S., Shima, T., Inada, K., Nakashima, A. Which types of regulatory T cells play important roles in implantation and pregnancy maintenance Am J Reprod Immunol 69, 340-345 (2013).
12. Zenclussen, A. C. et al. Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol 166, 811-822 (2005).
13. Wang, W. J. et al. Adoptive transfer of pregnancy-induced CD4+CD25+ regulatory T cells reverses the increase in abortion rate caused by interleukin 17 in the CBA/JxBALB/c mouse model. Hum Reprod 29, 946-952 (2014).
14. Guerin, L. R., Prins, J. R., Robertson, S. A. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment Hum Reprod Update 15, 517-535 (2009).
15. Darmochwal-Kolarz, D. et al. The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia. J Reprod Immunol 93, 75-81 (2012).
16. Sasaki, Y. et al. Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in pre-eclampsia. Clin Exp Immunol 149, 139-145 (2007).
17. Quinn, K. H., Lacoursiere, D. Y., Cui, L., Bui, J., Parast, M. M. The unique pathophysiology of early-onset severe preeclampsia: role of decidual T regulatory cells. J Reprod Immunol 91, 76-82 (2011).
18. Dai, S., Jia, R., Zhang, X., Fang, Q., Huang, L. The PD-1/PD-Ls pathway and autoimmune diseases. Cell Immunol 290, 72-79 (2014).
19. Gianchecchi, E., Delfino, D. V., Fierabracci, A. Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity. Autoimmun Rev 12, 1091-1100 (2013).
20. Francisco, L. M., Sage, P. T., Sharpe, A. H. The PD-1 pathway in tolerance and autoimmunity. Immunol Rev 236, 219-242 (2010).
21. Zhang, X. et al. Structural and functional analysis of the costimulatory receptor programmed death-1. Immunity 20, 337-347 (2004).
22. Nishimura, H., Nose, M., Hiai, H., Minato, N., Honjo, T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11, 141-151 (1999).
23. Nishimura, H. et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291, 319-322 (2001).
24. Song, M. Y. et al. Protective effects of Fc-fused PD-L1 on two different animal models of colitis. Gut 64, 260-271 (2015).
25. Fujiwara, H. et al. Programmed death-1 pathway in host tissues ameliorates Th17/Th1-mediated experimental chronic graft-versushost disease. J Immunol 193, 2565-2573 (2014).
26. Petroff, M. G. et al. B7 family molecules are favorably positioned at the human maternal-fetal interface. Biol Reprod 68, 1496-1504 (2003).
27. Taglauer, E. S., Trikhacheva, A. S., Slusser, J. G., Petroff, M. G. Expression and function of PDCD1 at the human maternal-fetal interface. Biol Reprod 79, 562-569 (2008).
28. D'Addio, F. et al. The link between the PDL1 costimulatory pathway and Th17 in fetomaternal tolerance. J Immunol 187, 4530-4541 (2011).
29. Zhang, Y. H., Tian, M., Tang, M. X., Liu, Z. Z., Liao, A. H. Recent Insight into the Role of the PD-1/PD-L1 Pathway in Feto-Maternal Tolerance and Pregnancy. Am J Reprod Immunol 74, 201-208 (2015).
30. Tripathi, S., Guleria, I. Role of PD1/PDL1 pathway, and TH17 and treg cells in maternal tolerance to the fetus. Biomed J 38, 25-31 (2015).
31. Wang, G., Hu, P., Yang, J., Shen, G., Wu, X. The effects of PDL-Ig on collagen-induced arthritis. Rheumatol Int 31, 513-519 (2011).
32. Raptopoulou, A. P. et al. The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis. Arthritis Rheum 62, 1870-1880 (2010).
33. Brown, C. et al. The effects of S-nitrosoglutathione and S-nitroso-N-acetyl-D, L-penicillamine in a rat model of pre-eclampsia. J Nat Sci Biol Med 4, 330-335 (2013).
34. Darmochwal-Kolarz, D. et al. Activated T lymphocytes in pre-eclampsia. Am J Reprod Immunol 58, 39-45 (2007).
35. Steinborn, A. et al. Distinct subsets of regulatory T cells during pregnancy: is the imbalance of these subsets involved in the pathogenesis of preeclampsia Clin Immunol 129, 401-412 (2008).
36. Cornelius, D. C., Lamarca, B. TH17-and IL-17-mediated autoantibodies and placental oxidative stress play a role in the pathophysiology of pre-eclampsia. Minerva Ginecol 66, 243-249 (2014).
37. Fu, B., Tian, Z., Wei, H. TH17 cells in human recurrent pregnancy loss and pre-eclampsia. Cell Mol Immunol 11, 564-570 (2014).
38. Toldi, G. et al. The frequency of peripheral blood CD4+CD25high FoxP3+ and CD4+CD25 FoxP3+ regulatory T cells in normal pregnancy and pre-eclampsia. Am J Reprod Immunol 68, 175-180 (2012).
39. Bengsch, B., Martin, B., Thimme, R. Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation. J Hepatol 61, 1212-1219 (2014).
40. Tanaka, K. et al. PDL1 is required for peripheral transplantation tolerance and protection from chronic allograft rejection. J Immunol 179, 5204-5210 (2007).
41. Guleria, I. et al. A critical role for the programmed death ligand 1 in fetomaternal tolerance. J Exp Med 202, 231-237 (2005).
42. Toldi, G. et al. Prevalence of Regulatory T-Cell Subtypes in Preeclampsia. Am J Reprod Immunol 74, 110-115 (2015).
43. Khalil, R. A., Crews, J. K., Novak, J., Kassab, S., Granger, J. P. Enhanced vascular reactivity during inhibition of nitric oxide synthesis in pregnant rats. Hypertension 31, 1065-1069 (1998).
44. Francisco, L. M. et al. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med 206, 3015-3029 (2009).
45. Agata, Y. et al. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 8, 765-772 (1996).
46. Sharpe, A. H., Wherry, E. J., Ahmed, R., Freeman, G. J. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 8, 239-245 (2007).
47. Parry, R. V. et al. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol 25, 9543-9553 (2005).
48. Kleffel, S. et al. Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth. Cell 162, 1242-1256 (2015).
49. Steer, P. J. Customised antenatal growth charts. Lancet 339, 878-879 (1992).
50. Peleg, D., Kennedy, C. M., Hunter, S. K. Intrauterine growth restriction: identification and management. Am Fam Physician 58, 453-460 (1998).
51. Cotechini, T. et al. Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia. J Exp Med 211, 165-179 (2014).
52. Szarka, A., Rigo, J. Jr., Lazar, L., Beko, G., Molvarec, A. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol 11, 59 (2010).
53. Kovo, M. et al. Pregnancy outcome and placental findings in pregnancies complicated by fetal growth restriction with and without preeclampsia. Reprod Sci 22, 316-321 (2015).
54. Zhang, Y., Liu, F., Chen, S., Zhong, M. Low-molecular-weight heparin protects kidney through an anti-apoptotic mechanism in a rat pre-eclamptic model. Eur J Obstet Gynecol Reprod Biol 188, 51-55 (2015).
55. Ramesar, S. V., Mackraj, I., Gathiram, P., Moodley, J. Sildenafil citrate improves fetal outcomes in pregnant, L-NAME treated, Sprague-Dawley rats. Eur J Obstet Gynecol Reprod Biol 149, 22-26 (2010).
56. Ma, R. Q., Sun, M. N., Yang, Z. Effects of preeclampsia-like symptoms at early gestational stage on feto-placental outcomes in a mouse model. Chin Med J (Engl) 123, 707-712 (2010).
57. Xue, P. et al. Single administration of ultra-low-dose lipopolysaccharide in rat early pregnancy induces TLR4 activation in the placenta contributing to preeclampsia. PLoS One 10, e0124001 (2015).
58. Schroeder, B. M. American College of Obstetricians and Gynecologists: ACOG practice bulletin on diagnosing and managing preeclampsia and eclampsia. American College of Obstetricians and Gynecologists. Am Fam Physician 66, 330-331 (2002).
59. Hamar, P. et al. Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury. Proc Natl Acad Sci USA 101, 14883-14888 (2004).
60. Suzuki, S., Toledo-Pereyra, L. H., Rodriguez, F. J., Cejalvo, D. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation 55, 1265-1272 (1993).